[{"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81553", "recalling_firm": "AMERICAN HEALTH PACKAGING", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0273-2019", "product_description": "Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100-count Unit Dose Blisters, Rx only, Amerisource Health Services DBA American Health Packaging, 2550-A John  Glenn Avenue Columbus, OH 43217, NDC 68084-446-01 (Individual Dose NDC: 68064-446-11)", "product_quantity": "4508 blister packs", "reason_for_recall": "Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that \"These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation.\"", "recall_initiation_date": "20181109", "center_classification_date": "20181120", "termination_date": "20200930", "report_date": "20181128", "code_info": "Lot#: 180310, 180612, Exp 03/31/20", "more_code_info": ""}, {"status": "Terminated", "city": "Biloxi", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79671", "recalling_firm": "Coastal Meds, LLC.", "address_1": "1759 Medical Park Dr Ste C", "address_2": "N/A", "postal_code": "39532-2154", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0719-2018", "product_description": "HYDROXOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532", "product_quantity": "1506 vials", "reason_for_recall": "Presence of Particulate matter. Recall due to presence of unknown particulate matter.", "recall_initiation_date": "20180405", "center_classification_date": "20180509", "termination_date": "20201124", "report_date": "20180502", "code_info": "Lots: CAH/101617 Discard by 04/14/2018; H/120117 Discard by 5/30/2018; H/010518 Discard by 7/4/2018; H/020718 Discard by 8/6/2018; H/021518 Discard by 8/14/2018 ; CAH/021218 Discard by 4/13/2018"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots; C262 BUD: 12/20/2018; D067 BUD: 03/21/2019; D072 BUD: 03/28/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 10mg pellet, 1 count (NDC 69761-010-01), 6 count (NDC 69761-010-06), 12 count (NDC 69761-010-12), and 30 count (NDC 69761-010-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0225-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0283-2018", "product_description": "Medline General Purpose Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "80 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1071; Lots: 17FA1640", "more_code_info": ""}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "address_2": "", "product_quantity": "247 bottles", "code_info": "Lot K022216C", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Healthful Naturals Leg Cramp Support Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906  NDC 68703-206-02", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0256-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0307-2018", "product_description": "Medline Suture Removal Tray, Sterile, Single Use Only. Packaged in Mexico by Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "49,587 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: MDS701550; Lots 16GB7687; 17HB5153; 16IB0427; 17GB3906; 17AB1937; 17CB7737; 16JB1136; 16JB1137  Pack Number: MDS701550H; Lots 16QB4583; 16IB0427; 17CB7737; 16MB6165; 17GB3906; 17AB1937; 16GB7687; 16JB1137; 17HB5153", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0073-2019", "product_description": "CVS Health, Original Strength, Triple Antibiotic Ointment Spray (bacitracin zinc 400 units, neomycin sulfate 3.5 mg, polymyxin B sulfate 5,000 units per gram), 2 OZ (57 g) can, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, Product#957603, UPC 0 50428 29525 0.", "product_quantity": "11,016 cans", "reason_for_recall": "Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "Lot: 170591E, Exp. 11/17/18"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0323-2019", "product_description": "Amlodipine and Valsartan Tablets, USP 10/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., NDC 0378-1724-93.", "product_quantity": "84,066 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot Numbers:  3066064, 3069645, 3069646, 3073142, 3073143, 3073144, 3077617"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["CODEINE-GUAIFENESIN"], "generic_name": ["CODEINE PHOSPHATE AND GUAIFENESIN"], "manufacturer_name": ["Method Pharmaceuticals, LLC"], "product_ndc": ["58657-500"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CODEINE PHOSPHATE", "GUAIFENESIN"], "rxcui": ["995868"], "spl_id": ["41b41a1f-2e84-3be6-e063-6294a90a888d"], "spl_set_id": ["fe126254-6ee6-48c3-965c-96e4276a5314"], "package_ndc": ["58657-500-04", "58657-500-16"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["GSL05Y1MN6", "495W7451VQ"]}, "product_type": "Drugs", "event_id": "78757", "recalling_firm": "Woodfield Pharmaceutical, LLC", "address_1": "10863 Rockley Rd", "address_2": "N/A", "postal_code": "77099-3405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0210-2018", "product_description": "Codeine-Guaifenesin Oral Solution 10-100 mg/5 mL Antitussive Expectorant ,16 fl. oz. , Manufactured For: Method Pharmaceuticals, LLC Arlington, TX 76006, NDC 58657-500-16", "product_quantity": "15,707 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkholderia cepacia", "recall_initiation_date": "20171212", "center_classification_date": "20180108", "termination_date": "20200124", "report_date": "20180117", "code_info": "Lot: 08616; Exp. 07/18", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0280-2018", "product_description": "Medline Suture Removal Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "700 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1018A; Lots: 17RB8658; 17HB1913", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81351", "recalling_firm": "Promise Pharmacy LLC", "address_1": "31818 US Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide.", "recall_number": "D-0239-2019", "product_description": "Prednisolone and Gatifloxacin Ophthalmic Solution, 1%/0.5%, 3 mL dropper bottle, Rx Only, 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "N/A", "reason_for_recall": "Presence of precipitate", "recall_initiation_date": "20181018", "center_classification_date": "20181108", "termination_date": "20201022", "report_date": "20181031", "code_info": "Lot#: 04092018@2, Exp 12/03/2018"}, {"country": "United States", "city": "Dayton", "address_1": "36 Stults Rd", "reason_for_recall": "Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.", "address_2": "", "product_quantity": "24 Viaflex Bag", "code_info": "Lot #: 180040003D, Exp 3/18/18", "center_classification_date": "20180329", "distribution_pattern": "Product was distributed to SC, FL, NY, NY,WA", "state": "NJ", "product_description": "15 units Oxytocin added to 0.9% Sodium Chloride Injection, 250 mL Viaflex Bag, Rx only, PharMEDium Serivces, LLC", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "PharMEDium Services, LLC", "recall_number": "D-0422-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79063", "termination_date": "20180424", "more_code_info": "", "recall_initiation_date": "20180205", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80213", "recalling_firm": "ICU Medical Inc", "address_1": "600 N FIELD DRIVE", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-0881-2018", "product_description": "0.45% Sodium Chloride Injection, USP, 100 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7730-37", "product_quantity": "88960 bags", "reason_for_recall": "Lack of assurance of sterility: Bags have potential to leak.", "recall_initiation_date": "20180531", "center_classification_date": "20180620", "termination_date": "20200604", "report_date": "20180627", "code_info": "Lot #: 85-023-JT, Exp 7/1/2019"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80397", "recalling_firm": "Aidarex Pharmaceuticals LLC", "address_1": "595 N Smith Ave", "address_2": "N/A", "postal_code": "92880-6920", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0991-2018", "product_description": "Enalapril Maleate, USP 5MG, 90-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: Wockhardt Ltd. India.  NDC: 33261-0693-90", "product_quantity": "61, 90-count bottles", "reason_for_recall": "Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.", "recall_initiation_date": "20180627", "center_classification_date": "20180725", "termination_date": "20191204", "report_date": "20180801", "code_info": "Lots: 51904-1, EXP: 01/31/2018; 51904-4, 52885-1, EXP: 03/31/2018; 52885-3, EXP: 04/30/2018; 52885-4,EXP: 05/28/2018; 53840-2,EXP: 5/28/2018; 53840-3, EXP:6/30/2018; 53840-4,  EXP:8/31/2018; 56665-1, EXP: 01/31/2019;  58596-1, EXP: 05/28/2019."}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077321"], "brand_name": ["LISINOPRIL"], "generic_name": ["LISINOPRIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-512", "68180-513", "68180-517", "68180-980", "68180-981", "68180-982", "68180-979", "68180-514", "68180-515", "68180-516"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISINOPRIL"], "rxcui": ["197884", "205326", "311353", "311354", "314076", "314077"], "spl_id": ["6723a96d-02f8-40c2-95ec-89a7053a7117"], "spl_set_id": ["7d6c31e2-b5a4-4279-8013-a8dad37ea73b"], "package_ndc": ["68180-512-02", "68180-512-30", "68180-512-09", "68180-512-01", "68180-512-03", "68180-513-30", "68180-513-03", "68180-513-01", "68180-513-09", "68180-513-02", "68180-513-05", "68180-517-03", "68180-517-01", "68180-517-30", "68180-517-09", "68180-517-04", "68180-517-02", "68180-980-03", "68180-980-30", "68180-980-01", "68180-980-09", "68180-980-05", "68180-980-02", "68180-981-01", "68180-981-03", "68180-981-30", "68180-981-09", "68180-981-02", "68180-981-05", "68180-982-01", "68180-982-02", "68180-982-30", "68180-982-03", "68180-982-09", "68180-979-01", "68180-979-03", "68180-979-30", "68180-979-09", "68180-514-01", "68180-514-02", "68180-514-03", "68180-514-09", "68180-514-30", "68180-514-05", "68180-515-01", "68180-515-02", "68180-515-03", "68180-515-09", "68180-515-30", "68180-515-05", "68180-516-01", "68180-516-02", "68180-516-03", "68180-516-09", "68180-516-30"], "is_original_packager": [true], "upc": ["0368180513018", "0368180512028", "0368180513032"], "unii": ["E7199S1YWR"]}, "product_type": "Drugs", "event_id": "80789", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States.", "recall_number": "D-1077-2018", "product_description": "Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03", "product_quantity": "11,706 bottles", "reason_for_recall": "Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.", "recall_initiation_date": "20180813", "center_classification_date": "20180813", "termination_date": "20191015", "report_date": "20180822", "code_info": "Lot #: H800414, Exp. 12/2019", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20171128@9, BUD 05/27/2018; 20171201@74, BUD 05/30/2018; 20171211@68, BUD 06/09/2018; 20171218@51, BUD 06/16/2018; 20171222@6, BUD 06/20/2018; 20180209@62, BUD 08/08/2018; 20180223@46, BUD 08/22/2018; 20180223@33, BUD 08/22/2018; 20180219@5, BUD 08/18/2018; 20171010@11, BUD 04/08/2018; 20171019@19, BUD 04/17/2018; 20171031@69, BUD 04/29/2018; 20171102@27, BUD 05/01/2018; 20171110@87, BUD 05/09/2018; 20171114@12, BUD 05/13/2018; 20171122@57, BUD 05/21/2018; 20180112@56, BUD 07/11/2018; 20180116@77, BUD 07/15/2018; 20180122@92, BUD 07/21/2018; 20180202@69, BUD 08/01/2018; 20180205@111, BUD 08/04/2018; 20180212@102, BUD 08/11/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Testosterone 200 mg pellet packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0662-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0181-2018", "product_description": "Hydroxocobalamin 1 mg/mL 30 mL Vial For IM Use, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "596 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 10162017@20 BUD: 2/13/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1088-2018", "product_description": "Medroxprogesterone 1% Ophthalmic Solution, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "STREE OVERLORD capsules, 3800 mg, 4-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class II", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0564-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20180219@90, BUD 08/18/2018", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Naltrexone 200 mg pellet, amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0648-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brea", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80277", "recalling_firm": "BioDiagnostic International", "address_1": "555 W Lambert Rd Ste C", "address_2": "N/A", "postal_code": "92821-3917", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to one sole customer in Illinois who further distributed Nationwide in the USA.", "recall_number": "D-0874-2018", "product_description": "Monsel's Solution (Ferric Subsulfate), 20%, packaged as 12 single application vials and 12 applicators, 8 mL per box, Manufactured For: MedGyn Products, Inc., 100 W. Industrial Rd., Addison, IL  60101 USA; Manufactured By: BioDiagnostics Intl, 555 West Lambert Road Unit-C, Brea, CA  92821, NDC 42721-112-08.", "product_quantity": "1000 boxes", "reason_for_recall": "CGMP Deviations: Products not manufactured under current good manufacturing practices.", "recall_initiation_date": "20180611", "center_classification_date": "20180614", "termination_date": "20190725", "report_date": "20180620", "code_info": "All lots within expiry"}, {"status": "Completed", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA203311"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-745", "31722-746", "31722-747", "31722-748"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["2b44fd7a-fd5a-984d-e063-6294a90a3fff"], "spl_set_id": ["0ff36e83-b307-42db-a2ab-bae3f6805c20"], "package_ndc": ["31722-745-30", "31722-745-90", "31722-745-05", "31722-745-31", "31722-745-32", "31722-746-30", "31722-746-90", "31722-746-05", "31722-746-31", "31722-746-32", "31722-747-30", "31722-747-90", "31722-747-05", "31722-747-31", "31722-747-32", "31722-748-30", "31722-748-90", "31722-748-05", "31722-748-31", "31722-748-32", "3317227479"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"], "upc": ["331722747905"]}, "product_type": "Drugs", "event_id": "80773", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1115-2018", "product_description": "Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 160 mg, 90 tablets Rx Only   Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854   By: Hetero Hetero Labs Limited, Unit V, Pollepally  Jadcherla Mahabubnagar - 509-301, India.   NDC 31722-747-90  UPC 331722747905", "product_quantity": "441,408 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180808", "center_classification_date": "20180823", "report_date": "20180829", "code_info": "All Lots with expiration dates 7/2018 to 6/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0305-2018", "product_description": "Medline Incision Drainage Kit, Sterile, Single Use Only. Packaged in Mexico by Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "149 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: P888943; Lots 17RB8662  Pack Number: P888943H; Lots 17RB8662", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0779-2018", "product_description": "Xalkori 250 mg cap NDC 00069-8140-20 30 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0459-2018", "product_description": "Nicardipine HCl in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Scottsdale", "address_1": "7373 N. Scottsdale Rd., Suite B-200", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.", "address_2": "", "product_quantity": "160,489 bottles", "code_info": "All lots within expiry.", "center_classification_date": "20180209", "distribution_pattern": "Nationwide in the USA.", "state": "AZ", "product_description": "Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ  85253; Manufactured by: Cornerstone Research and Development, Ogden, UT  84404, NDC 68040-606-16.", "report_date": "20180221", "classification": "Class I", "openfda": {}, "recalling_firm": "Primus Pharmaceuticals, Inc.", "recall_number": "D-0347-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "79055", "termination_date": "20190716", "more_code_info": "", "recall_initiation_date": "20180126", "postal_code": "85253", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80557", "recalling_firm": "MAJOR PHARMACEUTICALS", "address_1": "17177 N Laurel Park Dr", "address_2": "N/A", "postal_code": "48152-2693", "voluntary_mandated": "N/A", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide.", "recall_number": "D-0967-2018", "product_description": "Unit Dose Valsartan Tablets, USP. 160 mg. Rx only.,Distributed by:  Major Pharmaceuticals, Livonia, MI 48152, NDC# 0904-6594-61. NDC# 0904-6595-61.", "product_quantity": "4,556 cartons", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180718", "center_classification_date": "20180720", "termination_date": "20221002", "report_date": "20180801", "code_info": "Major Label Unit Dose 10 x 10 Cartons 160 mg Item # 302087. Lot# T-01269 (Expiry: 7/18). Lot# T-01524 (Expiry: 2/19). Lot# T-01646 (Expiry: 5/19). Lot# T-01668 (Expiry: 5/19). Lot# T-01788 (Expiry: 5/19)."}, {"status": "Terminated", "city": "Yardley", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206813"], "brand_name": ["POTASSIUM CITRATE"], "generic_name": ["POTASSIUM CITRATE"], "manufacturer_name": ["Strides Pharma Inc."], "product_ndc": ["42543-406", "42543-407", "42543-408"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CITRATE"], "rxcui": ["199376", "199381", "898490"], "spl_id": ["67ba2683-6fb5-429e-ab39-6f004ac33f1b"], "spl_set_id": ["5f38b02c-703c-4fc2-b833-654e41bd617f"], "package_ndc": ["42543-406-01", "42543-407-01", "42543-408-01"], "is_original_packager": [true], "unii": ["EE90ONI6FF"]}, "product_type": "Drugs", "event_id": "80553", "recalling_firm": "VENSUN PHARMACEUTICALS INC", "address_1": "790 Township Line Rd", "address_2": "N/A", "postal_code": "19067-4248", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Within the United States and Puerto Rico.", "recall_number": "D-1017-2018", "product_description": "Potassium Citrate Extended-Release Tablets, USP, 15 mEq, 100-count bottles, Rx only, Manufactured for: Vensun Pharmaceuticals, Inc. Yardley, PA 19067, Manufactured by: Strides Shasun Limited, Puducherry - 605 014, India, NDC 42543-408-01.", "product_quantity": "11,652 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Tablet breakage", "recall_initiation_date": "20180718", "center_classification_date": "20180727", "termination_date": "20190416", "report_date": "20180808", "code_info": "Lot #: 9570024, Exp. Jun-2019; 9570027, 9570029, Exp. Jul-2019; 7702088A, 7702089A, Exp. Aug-2019."}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1002-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder, Plantation Red MD, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0492-2018", "product_description": "Fluconazole USP for prescription compounding, packaged in a) 25g (NDC 58597-8268-4); b) 100g (NDC 58597-8268-6); c)1000g (NDC 58597-8268-8) RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "106200 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 051115-1, Exp. 4/30/2020; 081017-1, exp 11/30/2021; 122216-1,122216-2, Exp. 12/31/2020; b) 041017-1, Exp. 11/30/2021; 051115-1, Exp. 4/30/2020; 081017-1, exp 11/30/2021; c) 041017-1, 041017-2, Exp. 11/30/2021; 122216-1, 122216-2, exp. 12/31/2020"}, {"status": "Terminated", "city": "Asbury Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78991", "recalling_firm": "Flawless Beauty LLC", "address_1": "1215 Main St", "address_2": "N/A", "postal_code": "07712-5940", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed U.S.A. nationwide.", "recall_number": "D-0332-2018", "product_description": "Sterilized water for injections BP, 50 x 5 mL plastic ampules, Manufactured in India", "product_quantity": "N/A", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.", "recall_initiation_date": "20180119", "center_classification_date": "20180205", "termination_date": "20180913", "report_date": "20180214", "code_info": "all lots"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.", "address_2": "", "product_quantity": "100 syringes", "code_info": "Lot #: 6/12/18 0432 149-21072S, BUD 9/10/18", "center_classification_date": "20180625", "distribution_pattern": "Distributed to one medical center in Fort Worth, TX.", "state": "TX", "product_description": "fentanyl Citrate USP 5 mcg in 0.9% Sodium Chloride USP 0.5 mL, 10 mcg per mL prefilled syringe, Rx only, Advanced Pharma an FDA Regulated 503B Outsourcing Facility 9265 Kirby Dr., Houston, TX  77054, NDC 15082-210-72.", "report_date": "20180704", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0889-2018", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "80354", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20180620", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206245"], "brand_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "generic_name": ["HYDROCODONE BITARTRATE AND ACETAMINOPHEN"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-356", "43386-358", "43386-357"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "HYDROCODONE BITARTRATE"], "rxcui": ["856999", "857002", "857005"], "spl_id": ["2cb73d19-0ef9-4d59-a2de-b7b2b3a369a1"], "spl_set_id": ["26a2178e-e0e5-4d61-81fd-e30a3142f1f2"], "package_ndc": ["43386-358-05", "43386-358-01", "43386-358-10", "43386-358-03", "43386-357-01", "43386-357-05", "43386-357-10", "43386-357-03", "43386-356-01", "43386-356-05", "43386-356-10", "43386-356-03", "3433863561"], "is_original_packager": [true], "upc": ["0343386357031", "0343386358014", "0343386356010", "343386356102"], "unii": ["362O9ITL9D", "NO70W886KK"]}, "product_type": "Drugs", "event_id": "80187", "recalling_firm": "LUPIN SOMERSET", "address_1": "400 Campus Dr", "address_2": "N/A", "postal_code": "08873-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0836-2018", "product_description": "Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 5 mg/325 mg, 1000-count bottle Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset NJ 08873  Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 212020  NDC 43386-356-10  UPC 343386356102", "product_quantity": "1,672 (1000-count) bottles", "reason_for_recall": "Labeling: Missing Label", "recall_initiation_date": "20180524", "center_classification_date": "20180531", "termination_date": "20210126", "report_date": "20180606", "code_info": "Lot # S800257; Exp. 01/20"}, {"status": "Terminated", "city": "Seminole", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78939", "recalling_firm": "International Laboratories, Inc.", "address_1": "6950 Bryan Dairy Rd Ste A", "address_2": "N/A", "postal_code": "33777-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0234-2018", "product_description": "Pravastatin Sodium Tablets, USP, 20 mg, 30-count bottles, packaged in 12 x 30 tablets for individual patient dispensing per pharmacy dispenser carton, Rx only, Packaged for: International Laboratories, LLC. St. Petersburg, FL 33710, NDC 54458-926-16.", "product_quantity": "13,403 cartons", "reason_for_recall": "Presence of Foreign Tablets/Capsules: bottles could contain both pravastatin sodium 10 mg and 20 mg tablets in the same bottle.", "recall_initiation_date": "20180112", "center_classification_date": "20180124", "termination_date": "20190501", "report_date": "20180131", "code_info": "Lot: 117103A, Exp. 03/19"}, {"country": "United States", "city": "Olive Branch", "address_1": "1 & 2", "reason_for_recall": "Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.", "address_2": "154 Downing Street", "product_quantity": "Unknown", "code_info": "Lot #: 15517VP01, 15517VP02, 15517VP03, Exp 8/31/2019; 15518001, Exp 12/31/2019; 15518002, Exp 3/31/2020.", "center_classification_date": "20180907", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "state": "MS", "product_description": "Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-155-04.", "report_date": "20180829", "classification": "Class I", "openfda": {}, "recalling_firm": "Westminster Pharmaceuticals LLC", "recall_number": "D-1180-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80719", "termination_date": "20200603", "more_code_info": "", "recall_initiation_date": "20180803", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date.", "address_2": "", "product_quantity": "", "code_info": "lot# D001 EXP: 01/02/2018 CPD: 01/02/2019", "center_classification_date": "20180629", "distribution_pattern": "Nationwide in the USA", "state": "OK", "product_description": "TESTOSTERONE 200 mg PELLET, 1-count 3ml amber vial. RX only. Compounded by: Qualgen 14844 Bristol Park Blvd, Edmond OK 73013. NDC 69761-120-01", "report_date": "20180711", "classification": "Class III", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0893-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80203", "termination_date": "20201125", "more_code_info": "", "recall_initiation_date": "20180608", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "La Habra", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80890", "recalling_firm": "Auro Pharmacies, Inc.", "address_1": "520 W La Habra Blvd", "address_2": "N/A", "postal_code": "90631-5308", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in USA", "recall_number": "D-1166-2018", "product_description": "Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial,  Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631", "product_quantity": "40 vials", "reason_for_recall": "Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.", "recall_initiation_date": "20180821", "center_classification_date": "20180829", "termination_date": "20200130", "report_date": "20180905", "code_info": "Lot #: 180611/1, Exp 09-Sep-18"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "1,352 bags", "code_info": "Lot # 138-20181005@92, 138-20181005@91, 138-20181005@90, BUD 7/9/2018; 138-20181405@78, BUD 7/13/2018; 138-20181605@61, BUD 7/15/2018", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "Vancomycin 1.25gm in D5W 250 mL. ( Vancomycin HCL (USP) 1.25 gm, 5% Dextrose Inj. (USP) 250 mL) Volume: 262 mL. Single dose bag. Avella Specialty Pharmacy, 24416N 19th Avenue, Phoenix, AZ 85085. NDC 42852-617-25", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0941-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Upper Darby", "address_1": "6801 Ludlow St", "reason_for_recall": "Superpotent Drug: contains higher levels of Iron than labeled.", "address_2": "", "product_quantity": "1,155 boxes", "code_info": "Batch #: 579602, 579604, 579606, Exp 12/18; 579609, Exp 04/19.", "center_classification_date": "20181217", "distribution_pattern": "Nationwide in the USA.", "state": "PA", "product_description": "Monsel's (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bottles with applicators per box, Rx only, Gordon Laboratories, Upper Darby, PA  19082, NDC 10481-0112-8.", "report_date": "20181226", "classification": "Class II", "openfda": {}, "recalling_firm": "Gordon Laboratories", "recall_number": "D-0338-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81719", "termination_date": "20201202", "more_code_info": "", "recall_initiation_date": "20181210", "postal_code": "19082-2408", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0431-2018", "product_description": "Fentanyl Citrate and Bupivacaine HCl in 0.9% Sodium Chloride in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Completed", "city": "Jadcherla Mandal, Mahaboob Nagar", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA203311"], "brand_name": ["VALSARTAN"], "generic_name": ["VALSARTAN"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-745", "31722-746", "31722-747", "31722-748"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VALSARTAN"], "rxcui": ["349199", "349200", "349201", "349483"], "spl_id": ["2b44fd7a-fd5a-984d-e063-6294a90a3fff"], "spl_set_id": ["0ff36e83-b307-42db-a2ab-bae3f6805c20"], "package_ndc": ["31722-745-30", "31722-745-90", "31722-745-05", "31722-745-31", "31722-745-32", "31722-746-30", "31722-746-90", "31722-746-05", "31722-746-31", "31722-746-32", "31722-747-30", "31722-747-90", "31722-747-05", "31722-747-31", "31722-747-32", "31722-748-30", "31722-748-90", "31722-748-05", "31722-748-31", "31722-748-32", "3317227469"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["80M03YXJ7I"], "upc": ["331722746908"]}, "product_type": "Drugs", "event_id": "80773", "recalling_firm": "Hetero Labs Limited Unit V", "address_1": "Unit V (SEZ Unit I in APIIC SEZ)", "address_2": "Surv. No. 439-441, 458, Polepally Vill.", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1114-2018", "product_description": "Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 80 mg, 90 count bottles, Rx Only   Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854   By: Hetero Hetero Labs Limited Unit V. Polepally  Jadcherla Mahaboob Nagar - 509-301 India.    NDC 31722-746-90  UPC 331722746908", "product_quantity": "394,896 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180808", "center_classification_date": "20180823", "report_date": "20180829", "code_info": "All Lots with expiration dates 7/2018 to 6/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Scott", "state": "LA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78669", "recalling_firm": "Intrathecal Compounding Specialist, LLC", "address_1": "206 Jacobs Run", "address_2": "N/A", "postal_code": "70583-8907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0323-2018", "product_description": "All sterile drug preparations remaining within expiry prepared from Sufentanil Citrate Base  Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171130", "center_classification_date": "20180204", "termination_date": "20190501", "report_date": "20180214", "code_info": "All lots remaining within expiry (BUDs between November 15, 2017 and December 16, 2017)."}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0318-2018", "product_description": "Medline Suture Removal Tray,  Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "34,495 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: Z302-R; Lots 177B2075; 17RB9452; 17QB2640; 17CB4220  Pack Number: Z302-RH; Lots 177B2075; 17QB2640; 17RB9452; 17CB4220; 17NB1933; 17MB0084; 16LB3367", "more_code_info": ""}, {"status": "Terminated", "city": "Florham Park", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA079102"], "brand_name": ["ALTAVERA"], "generic_name": ["LEVONORGESTREL AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Xiromed, LLC."], "product_ndc": ["70700-116"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["238019", "748797", "748878", "1006065"], "spl_id": ["cd0fbf86-78dd-a8f2-7399-112a042ab767"], "spl_set_id": ["4701e72b-6378-a771-fb88-1b703031a8bc"], "package_ndc": ["70700-116-85", "70700-116-84"], "is_original_packager": [true], "upc": ["0370700116852"]}, "product_type": "Drugs", "event_id": "81044", "recalling_firm": "Xiromed LLC", "address_1": "180 Florham Park", "address_2": "Suite 101", "postal_code": "07932", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0016-2019", "product_description": "Altavera Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 mg, Rx only, 3 tablet dispensers x 28 tablets. Manufactured by Laboratories Leon Farma S.A., Spain, for Xiromed, LLC., Florham Park, NJ 07932. Product of Spain NDC 70700-116-85 (I unit x 28 tablets 70700-116-84)", "product_quantity": "40064 3x28  units", "reason_for_recall": "Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging component that may cause confusion.", "recall_initiation_date": "20180918", "center_classification_date": "20181011", "termination_date": "20190326", "report_date": "20181017", "code_info": "Lots: LF11838A Expiry May 2020; LF12107A, LF12106A, Expiry June 2020", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "6130 Cases", "code_info": "Product Code: 6904; Lots: 52850, 53281, EXP 08/31/2017; 53300, 53579, EXP 09/30/2017; 54320, EXP 10/31/2017; 54960, EXP 11/30/2017; 55753, EXP 12/31/2017; 56914, EXP 02/28/2018; 57352, EXP 04/30/2018; 57836, EXP 03/31/2018; 58349, EXP 04/30/2018; 59578, EXP 07/31/2018; 60712, EXP 09/30/2018; 61274, EXP 12/31/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q.Care Oral Cleansing & Suctioning System with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse q4. Contains 1 Suction Handle, Covered Yankauer and Y-Connector, 2 Untreated Suction Toothbrush packages, 2 Single dose bottles of 0.12% CHG Oral Rinse,  4 Suction Oral Swab packages with Perox-A-Mint solution, 2 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6904 UPC 6 18029 83008 1", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0398-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Tigard", "address_1": "8800 SW Commercial St", "reason_for_recall": "Labeling: Label Mix-Up: Customer complaint received that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg.", "address_2": "", "product_quantity": "2,400 bottles", "code_info": "Lot # 352300, Exp 01/19", "center_classification_date": "20180209", "distribution_pattern": "Nationwide in the USA", "state": "OR", "product_description": "Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles, Manufactured for: Basic Drugs, Inc., Vandalia, Ohio 45377, UPC Code 3 07610 22020 1.", "report_date": "20180221", "classification": "Class I", "openfda": {}, "recalling_firm": "Magno Humphries Laboratories, Inc", "recall_number": "D-0342-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "78952", "termination_date": "20191206", "more_code_info": "", "recall_initiation_date": "20180117", "postal_code": "97223-6252", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0444-2018", "product_description": "Dexamethasone Sodium Phosphate in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78487", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA", "recall_number": "D-0230-2018", "product_description": "bupPROPion HCL Extended-Release Tablets, USP (XL) 300 mg, 500-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. NDC: 0378-2009-05", "product_quantity": "1,414/500 count bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Mylan Pharmaceuticals Inc. is conducting a voluntary recall due to related out of specification compound results obtained during routine stability testing.", "recall_initiation_date": "20171103", "center_classification_date": "20180119", "termination_date": "20180614", "report_date": "20180131", "code_info": "Lot # 3077281, EXP 06-2018"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0028-2019", "product_description": "Rhinall (phenylephrine hydrochloride) Nasal Decongestant Nose Drops, 0.25%, 1 FL OZ (30 mL) bottle, Distributed by: Scherer Labs International, LLC., 330 Carswell Ave., Daytona Beach, FL 32117, UPC 3 02747 52531 1.", "product_quantity": "4040 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0281-2018", "product_description": "Medline GHS Suture Removal Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "1100 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1056; Lots: 17RB9450", "more_code_info": ""}, {"status": "Terminated", "city": "Pointe-Claire", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78887", "recalling_firm": "Odan Laboratories Ltd", "address_1": "325 Stillview Ave", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "distributed nationwide in the USA", "recall_number": "D-0232-2018", "product_description": "Dry to Normal Skin Starter Kit, Trousse debutante pour peau seche a normale. Kit includes:  (Vegetable Cleanser (60 ml / 2 oz), Night Cream (15 g / 0.5 oz), Day Cream SPF15 {Octinoxate 7%, Avobenzone 2% and Oxybenzone 5%} (15 g / 0.5 oz), Eye Cream (6 g / 0.21 oz).Made in Canada, Kamins Dermatologics Inc. Montreal, Quebec H9R 2Y6. Distributed by Kamins Dermatologics (USA) Inc. 99 Hudson, New York, NY, USA. UPC code 6 06354 61322 4", "product_quantity": "179 kits", "reason_for_recall": "Failed Stability Specifications:stability failure at 12 months, long term RT conditions.", "recall_initiation_date": "20171220", "center_classification_date": "20180124", "termination_date": "20180618", "report_date": "20180131", "code_info": "Lots # J203, J204, EXP 02-2018; J228, J274, EXP 09-2018"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0291-2018", "product_description": "Medline Straight Suture Removal Tray, Sterile, Single Use Only. Packaged in Mexico for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "10,298 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDR1186; Lots: 17EB0360; 177B1719  Pack Number: DYNDR1186H; Lots: 16PB7974; 17EB0360", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0535-2018", "product_description": "Ascorbic Acid USP, for prescription compounding, packaged in a) 100g (NDC 58597-8120-6); b) 500g (NDC 58597-8120-7); c) 1000g (NDC 58597-8120-8); d) 5000g (NDC 58597-8120-9); e) 25000g (NDC 58597-8120-3), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "200000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: b) 030816-1, Exp. 05/20/2018; c) 030816-1, Exp. 05/20/2018; d) 030816-3, Exp. 05/20/2018; e) 030816-2, Exp. 05/20/2018;"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204193"], "brand_name": ["DOCETAXEL"], "generic_name": ["DOCETAXEL"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc."], "product_ndc": ["43598-610", "43598-611"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOCETAXEL"], "rxcui": ["1860480", "1860485"], "spl_id": ["948f7c4c-6a40-d240-3eb3-d9ae6e371429"], "spl_set_id": ["be3df07d-ea56-453a-25ad-c3cedc22712a"], "package_ndc": ["43598-611-11", "43598-610-40"], "is_original_packager": [true], "unii": ["15H5577CQD"]}, "product_type": "Drugs", "event_id": "78842", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide in the USA, Uzbekistan, and Myanmar", "recall_number": "D-0213-2018", "product_description": "Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11", "product_quantity": "1,051 vials", "reason_for_recall": "Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.", "recall_initiation_date": "20170109", "center_classification_date": "20180112", "termination_date": "20181204", "report_date": "20180117", "code_info": "Lot #: H7044, Exp 05/19", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0767-2018", "product_description": "Tecfidera 240 mg capsule NDC 64406-0006-02 30 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0166-2019", "product_description": "Lipo MIC-12 Compound Injectable a) NDC 69699-1603-10; b) 30 mL Stock Solution Compound Injectable NDC 69699-1603-30, Pharm D Solutions, Houston, Texas", "product_quantity": "896 vials; 64000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: a) 09042018:66/A Discard by: 3/3/2019; 07302018:65 Discard by: 1/26/2019; b) 08132018:75/A Discard by: 2/1/2019; 04172018:16  Discard by: 9/30/2018; 03212018:27 Discard by: 9/17/2018; 04242018:82 Discard by: 10/20/2018; 05142018:72 Discard by: 11/10/2018; 06192018:67 Discard by: 12/18/2018; 08142018:00 Discard by: 2/1/2019; 07302018:64 Discard by: 1/26/2019"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "700 bags", "code_info": "Lot # 4/30/18 0512 2-82325P, BUD 6/14/2018; 5/22/18 1238 82325P, BUD 7/6/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "EPINEPHrine (USP) 4 mg, 0.9% Sodium Chloride (USP) 250 mL Volume: 254 mL single dose bag. Avella of Houston, 9265 Kirby Dr., Houston, TX 77054. NDC 42852-823-25.", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0932-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "4 vials", "code_info": "Lot#: 20180220@4, BUD 03/22/2018, 20180221@14, BUD 03/23/2018, 20180228@1, BUD 03/30/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Vitamin D 50,000 unit/ml, 5 mL amber vial, Injectable Liquid, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. # 101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0646-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Indiana", "address_1": "625 Kolter Dr Ste 4", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "address_2": "", "product_quantity": "9 bottles of 90 = 810 tablets", "code_info": "Lot # B0335344-081717, exp. date 08/2018  Lot # B0363364-110917, exp. date 11/2018  Lot # B0391225-012218, exp. date 01/2019  Lot # B0408458-030618, exp. date 03/2019  Lot # B0384871-010318, exp. date 01/2019  Lot # B0436862-051518, exp. date 05/2019", "center_classification_date": "20180816", "distribution_pattern": "Product was distributed to three customers in FL and VA.", "state": "PA", "product_description": "Valsartan 80 mg Tablet,s HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 Kolter Drive, Suite 4, Indiana, PA 15701, NDC 61786-0791-19", "report_date": "20180822", "classification": "Class II", "openfda": {}, "recalling_firm": "RemedyRepack Inc.", "recall_number": "D-1100-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80827", "termination_date": "20181012", "more_code_info": "", "recall_initiation_date": "20180810", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["SPARKLEFRESH"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-083"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["27d69435-782e-9b40-e063-6394a90a93f4"], "spl_set_id": ["1565528b-89f2-4c97-b294-15b6ebd3f80e"], "package_ndc": ["53329-083-21", "53329-083-92", "53329-083-93", "53329-083-94", "53329-081-93"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "81381", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0247-2019", "product_description": "SparkleFresh Fluoride Toothpaste, Sodium Monofluorophosphate 0.76%, a) 17 g tube (NDC 53329-083-92, product number NONTP6I), b) 24 g tube (NDC 53329-083-93, product number NONTP85I), c) 42.5 g (NDC 53329-083-21, product number NONTP15I), d) 24 g tube (NDC 53329-081-93, product number DGN1000), Made in Malaysia for Medline Industries, Inc., Three Lakes Drive, Northfield, IL 60093 USA", "product_quantity": "994,756 tubes", "reason_for_recall": "Microbial Contamination of Non-Sterile Product", "recall_initiation_date": "20180917", "center_classification_date": "20181115", "termination_date": "20200904", "report_date": "20181114", "code_info": "a) Lot 102920C, exp 10/29/2020 and 111220C, exp 11/11/2020; b) 111620D, exp 11/16/2020; c) 111420D, exp 11/14/2020;  d) 111720C, exp 11/17/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Foshan", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80614", "recalling_firm": "Longbow First Aid Products Manufactory", "address_1": "Building F/2", "address_2": "A3 Guiping Road; Hantian Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY and CA.", "recall_number": "D-1049-2018", "product_description": "Eyewash Purified water 98.3%, Ophthalmic Solution, packaged in a) 4 FL OZ (NDC 6910-3218-07) and b) 8 Fl OZ (NDC 6910-3218-08) bottles, 77656 Flora Rd, Palm Desert, CA 92211.", "product_quantity": "14,400 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20180717", "center_classification_date": "20180808", "termination_date": "20190911", "report_date": "20180815", "code_info": "Lot #: a) 20171215 and 20171016, b) 20171016"}, {"status": "Terminated", "city": "La Habra", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80890", "recalling_firm": "Auro Pharmacies, Inc.", "address_1": "520 W La Habra Blvd", "address_2": "N/A", "postal_code": "90631-5308", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in USA", "recall_number": "D-1162-2018", "product_description": "Methyl-Cobalamin injectable, 10 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631", "product_quantity": "81 vials", "reason_for_recall": "Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.", "recall_initiation_date": "20180821", "center_classification_date": "20180829", "termination_date": "20200130", "report_date": "20180905", "code_info": "Lot #: 180702/1, Exp 30-Sep-18"}, {"country": "United States", "city": "Nicholasville", "address_1": "200 Moore Dr", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Expiration Date; vial indicates a 1 year expiration date instead of a 6 month expiration date", "address_2": "", "product_quantity": "10,280 Vials", "code_info": "Lot, exp: 7101804, 7111807, 7131807, 7151801, 7161804, 7181805, 7191801, 7201803, 7211801, 7221801, 7231805, 7241803, 7251803, 7261802, 7271801, 7281801, 7301805, 7311805, exp 7/19;  8021801, 8031801, 8041801, 8081802, 8091804, 8101803, 8111810, 8121801, 8141801, 8161803, 8171803, 8201801, 8251801, exp 8/19", "center_classification_date": "20181107", "distribution_pattern": "Nationwide USA", "state": "KY", "product_description": "Tesamorelin, 1mg/vial, 6mL vial, Lyophilized Powder for Reconstitution and Subcutaneous Injection, Rx Only, Tailor Made Compounding, Nicholasville, KY 40356", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Tailor Made Compounding", "recall_number": "D-0223-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81337", "termination_date": "20190821", "more_code_info": "", "recall_initiation_date": "20180928", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northbrook", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021506"], "brand_name": ["MYCAMINE"], "generic_name": ["MICAFUNGIN SODIUM"], "manufacturer_name": ["Astellas Pharma US, Inc."], "product_ndc": ["0469-3211", "0469-3250"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["MICAFUNGIN SODIUM"], "rxcui": ["861379", "861381", "861383", "861385"], "spl_id": ["cf33a1ae-ae66-4e64-8a9b-42b81188b179"], "spl_set_id": ["a064c4a7-25ec-4a2c-afc2-703491a4a38b"], "package_ndc": ["0469-3250-10", "0469-3211-10"], "is_original_packager": [true], "unii": ["IS1UP79R56"]}, "product_type": "Drugs", "event_id": "78981", "recalling_firm": "Astellas Pharma US Inc", "address_1": "1 Astellas Way", "address_2": "N/A", "postal_code": "60062-6111", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0548-2018", "product_description": "Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only  Marketed by: Astellas Pharma US, Inc. Northbrook, IL 60062, NDC 0469-3211-10", "product_quantity": "63600 vials", "reason_for_recall": "Labeling: Label Error on Declared Strength", "recall_initiation_date": "20180122", "center_classification_date": "20180227", "termination_date": "20190501", "report_date": "20180214", "code_info": "Lots: F1700164 Exp. 02/20; A000000220 Exp. 06/20"}, {"status": "Terminated", "city": "Chestnut Ridge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80969", "recalling_firm": "Par Pharmaceutical, Inc.", "address_1": "1 Ram Ridge Rd", "address_2": "N/A", "postal_code": "10977-6714", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States nationwide", "recall_number": "D-1185-2018", "product_description": "Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11", "product_quantity": "16,207 (bottles of 30 tablets)", "reason_for_recall": "Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.", "recall_initiation_date": "20180906", "center_classification_date": "20180910", "termination_date": "20191206", "report_date": "20180919", "code_info": "Lot #: 29906202, Exp 12/18; 29993102, Exp 2/19; 30366102, 30373103, Exp 4/19; 31940601, Exp 3/20."}, {"country": "United States", "city": "Boca Raton", "address_1": "6111 Broken Sound Pkwy NW Ste 170", "reason_for_recall": "Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.", "address_2": "", "product_quantity": "9,193 bottles", "code_info": "Lot #: 5599.008A,  5599.009A, 5599.010A, Exp. 04/2019;    5599.012A,  5599.013A, Exp. 11/2019;  5599.014A, Exp. 01/2020", "center_classification_date": "20181120", "distribution_pattern": "Nationwide within the United States", "state": "FL", "product_description": "Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "Breckenridge Pharmaceutical, Inc.", "recall_number": "D-0279-2019", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "81523", "termination_date": "20191126", "more_code_info": "", "recall_initiation_date": "20181106", "postal_code": "33487-2875", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1092-2018", "product_description": "PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Injection, 18mcg/1.8 mg/0.2 mg/0.02 mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Jeannette", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80633", "recalling_firm": "Ranier's Compounding Laboratory", "address_1": "1107 Lowry Ave", "address_2": "", "postal_code": "15644-3030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed within the state of Pennsylvania.", "recall_number": "D-1080-2018", "product_description": "Atropine 0.01% Opth Solution, 5 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA  15644.", "product_quantity": "5 droptainers", "reason_for_recall": "Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20180725", "center_classification_date": "20180815", "termination_date": "20220901", "report_date": "20180822", "code_info": "All lots within expiry", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20180130@61, BUD 07/29/2018; 20180208@17, BUD 08/07/2018,   20170928@27, BUD 03/27/2018; 20171025@49, BUD 04/23/2018; 20171109@42, BUD 05/08/2018; 20171117@1, BUD 05/16/2018; 20180130@96, BUD 07/29/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Testosterone 25 mg pellet packaged in amber vial,   Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave.   #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0664-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "81020", "recalling_firm": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "address_1": "508 Carnegie Ctr", "address_2": "", "postal_code": "08540-6259", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0017-2019", "product_description": "treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable suspension. Kit Contents: 2 packs ABILIFY Tablets 10mg (14 day supply) plus 1 ABILIFY MAINTENA Pre-filled Dual Chamber Syringe Kit. Rx only. Not for sale or reimbursement. Distributed and Marketed by: Otsuka America Pharmaceutical, Inc. Rockville, MD 20850. Marketed by: Deerfield, IL 60015 USA. Bar Code DCSKit-59148-10Tabs-01", "product_quantity": "17325 kits", "reason_for_recall": "Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.", "recall_initiation_date": "20180917", "center_classification_date": "20181012", "termination_date": "20220309", "report_date": "20181010", "code_info": "Lots: 7F92YUD3H1A/AIS1017B,  7F92YUD3H1A/AIS1017C, EXP 30-Jun-2020.", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0458-2018", "product_description": "Ropivacaine HCl Injection in all strengths, all doses, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA071017"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["53489-145", "53489-146"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198334", "198335"], "spl_id": ["31dd7abe-e7f2-10df-e063-6394a90a93e2"], "spl_set_id": ["4833319a-a7b3-4bf4-bec4-6531b43182d4"], "package_ndc": ["53489-145-01", "53489-145-05", "53489-146-01", "53489-146-05"], "is_original_packager": [true], "upc": ["0353489146012", "0353489145015"], "nui": ["N0000175489", "N0000000191", "N0000187062", "N0000187061", "N0000175504", "M0020790", "N0000185504"], "pharm_class_epc": ["Dihydrofolate Reductase Inhibitor Antibacterial [EPC]", "Sulfonamide Antimicrobial [EPC]"], "pharm_class_moa": ["Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "pharm_class_cs": ["Sulfonamides [CS]"], "unii": ["AN164J8Y0X", "JE42381TNV"]}, "product_type": "Drugs", "event_id": "79909", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "", "postal_code": "08512-3605", "voluntary_mandated": "", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0802-2018", "product_description": "Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg, Rx Only, 500-count bottle, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St., Philadelphia, PA 19124, Dist, by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC 53489-146-05", "product_quantity": "1,908 500-count bottles", "reason_for_recall": "Presence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (500 ct.)  because a foreign matter identified as polyethylene was detected in two (2) tablets.", "recall_initiation_date": "20180419", "center_classification_date": "20180511", "termination_date": "20190228", "report_date": "20180523", "code_info": "Lot 6848501, EXP 04/2020", "more_code_info": ""}, {"country": "United States", "city": "Columbia", "address_1": "3801 Mojave Ct Ste 101", "reason_for_recall": "Stability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.", "address_2": "", "product_quantity": "144 bags", "code_info": "Lot#: AC-015565, Exp. 03/26/2018", "center_classification_date": "20180329", "distribution_pattern": "Medical Facility in MO", "state": "MO", "product_description": "Vancomycin 1g added to 250mL of 0.9% Sodium Chloride IV bag, Rx only, APOLLOcare, 3801 Mojave Ct., Suite 101, Columbia, MO 65202, NDC 71170-254-25.", "report_date": "20180404", "classification": "Class II", "openfda": {}, "recalling_firm": "Apollo Care", "recall_number": "D-0614-2018", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "79517", "termination_date": "20180531", "more_code_info": "", "recall_initiation_date": "20180307", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207160"], "brand_name": ["LEVETIRACETAM"], "generic_name": ["LEVETIRACETAM IN SODIUM CHLORIDE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-246", "55150-247", "55150-248"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["1193358", "1193360", "1193362"], "spl_id": ["2e0b32db-b6e3-4a68-a752-e4923f4bd84a"], "spl_set_id": ["e5eb4c89-8ee9-4474-9cb1-c3b3dc262a4a"], "package_ndc": ["55150-246-47", "55150-247-47", "55150-248-47"], "is_original_packager": [true], "upc": ["0355150248476"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"]}, "product_type": "Drugs", "event_id": "79772", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0706-2018", "product_description": "Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg per 100 mL (10 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-247-47.", "product_quantity": "188941 bags", "reason_for_recall": "Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap", "recall_initiation_date": "20180327", "center_classification_date": "20180503", "termination_date": "20220218", "report_date": "20180509", "code_info": "Lot/Batch #'s:  CLV160013, CLV160014 and CLV160015, exp Sept 2018; CLV160022, CLV160023, CLV160024, CLV160025, CLV160026, CLV160027, CLV160028, CLV160029, CLV160030 exp Oct 2018; CLV170002, Dec 2018; CLV170010, exp April 2019; CLV170027, CLV170028, CLV170029 and CLV170030 exp Oct 2019"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206935"], "brand_name": ["IRINOTECAN HYDROCHLORIDE"], "generic_name": ["IRINOTECAN HYDROCHLORIDE"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "product_ndc": ["50742-401", "50742-402"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRINOTECAN HYDROCHLORIDE"], "rxcui": ["1726319", "1726324"], "spl_id": ["096d9fbd-b19c-4ade-a601-1ddad80c0218"], "spl_set_id": ["d04f2471-3085-4fc8-a657-bb3918d48e6e"], "package_ndc": ["50742-401-02", "50742-402-05"], "is_original_packager": [true], "upc": ["0350742401024", "0350742402052"], "unii": ["042LAQ1IIS"]}, "product_type": "Drugs", "event_id": "80254", "recalling_firm": "Ingenus Pharmaceuticals Llc", "address_1": "4190 Millenia Blvd", "address_2": "", "postal_code": "32839-6408", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0891-2018", "product_description": "Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial, Rx Only, Manufactured for: Ingenius Pharmaceuticals, LLC, Orlando, FL 32839-6408; Manufactured by: Ingenius Pharmaceuticals, GmbH Ticino 6917, Switzerland, NDC 50742-401-02.", "product_quantity": "14089 vials", "reason_for_recall": "Superpotent Drug: High out of specification assay value results for potency.", "recall_initiation_date": "20180608", "center_classification_date": "20180629", "termination_date": "20190501", "report_date": "20180711", "code_info": "Lot #: 17034-2, 17035-2, 17036-2; Exp. 08/19", "more_code_info": ""}, {"status": "Terminated", "city": "Waukon", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80963", "recalling_firm": "Beaumont Bio-med, Inc.", "address_1": "21 1st Ave NE", "address_2": "N/A", "postal_code": "52172-1705", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1194-2018", "product_description": "Sore Throat & Laryngitis Response Homeopathic Formula, 2 FL. OZ. (59.2 mL) per amber glass oral spray bottle, Distributed by Beaumont Bio-Med, Inc., Waukon, IA 52172;  NDC 58066-7014-7", "product_quantity": "420 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20180831", "center_classification_date": "20180917", "termination_date": "20220916", "report_date": "20180926", "code_info": "Lot: 100316G, Exp 10/2019; 050118R, Exp 05/2021"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0309-2018", "product_description": "Medline Suture Removal Tray, Sterile, Single Use Only. Packaged in Mexico by Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "98,901 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: MDS708550; Lots 17GB4997;  17TB7125;  17RB7896;  17HB3784;  17HB4133;  17RB7895;  17FB1724;  17FB2572;  Pack Number: MDS708550H; Lots 17GB4997;  17RB7896;  17PB5544;  17FB1724;  16JB1135;  17TB7125;  16SB9345;  17FB2572;  17FB2571;  17RB7895;  17HB3784;  16NB7654;  17FB1721;  16LB8439;  17HB4133;  16WB1269;  16NB8410;  15VB7079", "more_code_info": ""}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78822", "recalling_firm": "Marksans Pharma Inc.", "address_1": "Suite # 401, 4th Floor", "address_2": "Room No. 430, 150 Motor Parkway", "postal_code": "11788", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to repackaging firms in NY who then distributed Nationwide in the USA.", "recall_number": "D-0238-2018", "product_description": "Ibuprofen Tablets, USP 400 mg, 6 x 3500 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-121-29.", "product_quantity": "21,584,100 tablets", "reason_for_recall": "CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.", "recall_initiation_date": "20180109", "center_classification_date": "20180124", "termination_date": "20200526", "report_date": "20180131", "code_info": "Lot #: HK6001, HK6002, HK6003, HK6004, HK6005, HK6006, HK6007, HK6008, HK6009, HK6010, HK6011, HK6012, HK6013, HK6014, HK6015, Exp 09/18"}, {"status": "Terminated", "city": "Biloxi", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79671", "recalling_firm": "Coastal Meds, LLC.", "address_1": "1759 Medical Park Dr Ste C", "address_2": "N/A", "postal_code": "39532-2154", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0717-2018", "product_description": "CYANOCOBALAMIN Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532", "product_quantity": "745 vials", "reason_for_recall": "Presence of Particulate matter. Recall due to presence of unknown particulate matter.", "recall_initiation_date": "20180405", "center_classification_date": "20180509", "termination_date": "20201124", "report_date": "20180502", "code_info": "Lot: C/010218 Discard by 07/01/2018; CAC/013118 Discard by 4/1/2018; CAC/020518 Discard by 4/6/2018; CAC/021418 Discard by 4/15/2018"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016733"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-2201"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["35e26a6d-60d6-4388-84e9-c481a3b69ee7"], "spl_set_id": ["0d59a04a-32e6-485b-b638-a1e6c09e9642"], "package_ndc": ["0264-2201-00", "0264-2201-10", "0264-2201-50", "0264-2201-70"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "79348", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "N/A", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0549-2018", "product_description": "0.9% Sodium Chloride Irrigation USP, 1000 mL Plastic Irrigation Container (PIC), Rx only, B. Braun Medical Inc., Irvine, CA  92614, Catalog # R5200-01, NDC 0264-2201-00.", "product_quantity": "17,360 plastic irrigation containers", "reason_for_recall": "Presence of Particulate Matter: Customer complaint of particulate matter which has been identified as polyethylene, which is consistent with the material used to manufacture the container cap was received.", "recall_initiation_date": "20180216", "center_classification_date": "20180227", "termination_date": "20200123", "report_date": "20180307", "code_info": "Batch # J7N912, Exp 10/31/20"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0780-2018", "product_description": "Temozolomide 20 mg NDC 43975-0253-05 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0171-2019", "product_description": "Phenol 7% and Glycerin Aqueous Solution 10 mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1432-10", "product_quantity": "630 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 08082018:86 Discard by: 2/4/2019"}, {"status": "Terminated", "city": "Maple Grove", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209916"], "brand_name": ["BUMETANIDE"], "generic_name": ["BUMETANIDE"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "product_ndc": ["0832-0540", "0832-0541", "0832-0542"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUMETANIDE"], "rxcui": ["197417", "197418", "197419"], "spl_id": ["d53166d9-64ca-4b76-81a7-b70a60c53b12"], "spl_set_id": ["ff5dc8c6-b2f2-41d3-8e56-a953aa721b59"], "package_ndc": ["0832-0540-11", "0832-0541-11", "0832-0541-10", "0832-0542-11", "0832-0542-10"], "is_original_packager": [true], "upc": ["0308320540115", "0308320541112"], "nui": ["N0000175366", "N0000175590"], "pharm_class_pe": ["Increased Diuresis at Loop of Henle [PE]"], "pharm_class_epc": ["Loop Diuretic [EPC]"], "unii": ["0Y2S3XUQ5H"]}, "product_type": "Drugs", "event_id": "81174", "recalling_firm": "Upsher Smith Laboratories, Inc.", "address_1": "6701 Evenstad Dr N", "address_2": "N/A", "postal_code": "55369-6026", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico and Guam", "recall_number": "D-0280-2019", "product_description": "Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by:  Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11", "product_quantity": "44,764 bottles", "reason_for_recall": "Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.", "recall_initiation_date": "20180919", "center_classification_date": "20181121", "termination_date": "20200930", "report_date": "20181031", "code_info": "Lot#:  375716, Exp 4/30/2020; 372957, 372958, 372959, Exp 3/31/2020; 374541, 375717, 376688, Exp 5/31/2020"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "13,041 cases", "code_info": "Product Code: 6414; Lots: 57847, EXP 09/18/2017; 57852, 57875, EXP 08/14/2017; 58246, EXP 09/20/2017; 58802, 58851, EXP 10/09/2017; 58924, 59091, 59116, EXP 11/03/2017; 59494, EXP 11/27/2017; 60123, EXP 01/02/2018; 60466, 60880, 60925, 01/22/2018; 61364, 03/05/2018; 61705, EXP03/30/2018; 62061, EXP 04/17/2018; 62076, EXP 04/27/2018", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q CARE q4 Oral Cleansing & Suctioning System, Contains 1 Covered Yankauer and Y-Connector, 2 Suction Toothbrush packages with  Antiplaque solution, 4 Suction Oral Swab packages with  Antiseptic  Oral Rinse,  2 Oropharyngeal Suction Catheter packages, Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6414 UPC 6 18029 84138 4", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0375-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Windsor", "address_1": "755 Rainbow Rd Ste B", "reason_for_recall": "Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.", "address_2": "", "product_quantity": "196 bags", "code_info": "Lot # 20180328@25, Exp 06/26/2018", "center_classification_date": "20180702", "distribution_pattern": "Product was distributed throughout the United States.", "state": "CT", "product_description": "Phenylephrine HCL 80mg in 0.9% Sodium Chloride 250 mL Bag (320 mcg/mL), SCA Pharmaceuticals, LLC, Windsor, CT", "report_date": "20180711", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals, LLC", "recall_number": "D-0905-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80303", "termination_date": "20190204", "more_code_info": "", "recall_initiation_date": "20180614", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "4650 Cases", "code_info": "Product Code: 6613; Lots: 51330, EXP 08/08/2017; 52400, EXP 10/03/2017;    53198, EXP 11/28/2017; 54582, EXP 02/27/2018; 55837, EXP 05/22/2018, 57007, EXP 08/07/2018; 57904, EXP 09/25/2018; 58931, EXP 11/06/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Oral Care Suction Swabs with Perox-A-Mint solution. Contains 2 Suction Swabs with sodium bicarbonate, 0.25 fl oz/ 7ml Perox-A-Mint solution, 0.07 oz/2g Mouth Moisturizer, 1 Applicator Swab. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6613", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0390-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79062", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide within the United States", "recall_number": "D-0542-2018", "product_description": "Fentanyl Transdermal System. 75 mcg/h, packaged in 5 pouch system (NDC 0591-3213-72),  Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3213-54.", "product_quantity": "576, 760 (5 pouches/carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits", "recall_initiation_date": "20180129", "center_classification_date": "20180222", "termination_date": "20180905", "report_date": "20180214", "code_info": "Lot #: 1107745A, Exp. Mar 2018;1122452A, 1137109A, Exp. Jun 2018; 1144515A, Exp. Oct 2018; 1189477A, Exp. Mar 2019; 1215224A, Exp. Aug 2019."}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1006-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder,  Red Borneo, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot #: 20180123@4, BUD 4/14/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "Methionine 25mg/Inositol 50mg/Choline 50mg/ B12 1mg, 50 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0647-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0203-2019", "product_description": "Trimix ST-1 30PA-1.5PH-50A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1388-05", "product_quantity": "40 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05312018:12 Discard by: 11/27/2018; 07242018:04 Discard by: 1/20/2019"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79265", "recalling_firm": "SCA Pharmaceuticals, LLC.", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "GA, NE & PA", "recall_number": "D-0603-2018", "product_description": "labetalol HCl injection 20 mg/4 mL (5mg/mL), 4 mL syringe, Rx Only, for IV Use, SCA Pharmaceuticals, Windsor, CT 06095 --- NDC 70004-0700-28, UPC 70004070028", "product_quantity": "480 syringes", "reason_for_recall": "Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018", "recall_initiation_date": "20180222", "center_classification_date": "20180319", "termination_date": "20190226", "report_date": "20180314", "code_info": "lot 1217000213, exp 03/27/2019"}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0035-2019", "product_description": "CVS Health, Saline Nasal Spray, 1.5 FL OZ bottle, Distributed by CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895, Product #277790.", "product_quantity": "552 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0737-2018", "product_description": "Pediasure Liq. Vanilla G+G (CAN) #24 24 days supply, NDC 70074-0558-98", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Palm Springs", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "79338", "recalling_firm": "Oxygen Development Llc", "address_1": "1525 S Congress Ave", "address_2": "N/A", "postal_code": "33406-5916", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Canada", "recall_number": "D-0584-2018", "product_description": "Life Brand Clear Action Acne Treatment Concealer Stick (Salicylic acid), 1.9g, Imported for: Shoppers Drug Mart Pharmaprix Toronto, M2J4W8, UPC 057800062653", "product_quantity": "12216 sticks", "reason_for_recall": "Superpotent drug: failed assay throughout the stick after 6 months stability.", "recall_initiation_date": "20180124", "center_classification_date": "20180309", "termination_date": "20190403", "report_date": "20180314", "code_info": "Lot #: 060E"}, {"country": "United States", "city": "Oshkosh", "address_1": "2155 S Oakwood Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "address_2": "", "product_quantity": "67 bottles", "code_info": "Lot K061417B", "center_classification_date": "20181119", "distribution_pattern": "Nationwide USA", "state": "WI", "product_description": "Native Remedies VertiFree Oral Spray, 2 fl oz (59 mL) per bottle, Distributed by:  Silver Star Brands, Oshkosh, WI 54906.  NDC 68703-253-02", "report_date": "20181114", "classification": "Class I", "openfda": {}, "recalling_firm": "Silver Star Brands", "recall_number": "D-0251-2019", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "81228", "termination_date": "20190825", "more_code_info": "", "recall_initiation_date": "20181003", "postal_code": "54904-6359", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Olive Branch", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81668", "recalling_firm": "Westminster Pharmaceuticals Llc", "address_1": "1 & 2", "address_2": "154 Downing Street", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0301-2019", "product_description": "Westminster Irbesartan Tablets, USP 150 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-120-01; b) 90 count bottle NDC 69367-120-03", "product_quantity": "2319 bottles", "reason_for_recall": "CGMP Deviations: FDA laboratory testing confirmed traces of NDEA  impurity in specific lots of Irbesartan.", "recall_initiation_date": "20181029", "center_classification_date": "20181214", "termination_date": "20211026", "report_date": "20181219", "code_info": "Batch Numbers: a) B161005A Exp. 09/30/2019, C161002A Exp. 02/29/2020; b) B161005B Exp. 09/30/2019, C161002B Exp. 02/29/2020"}, {"country": "United States", "city": "Staten Island", "address_1": "119 Linwood Ave", "reason_for_recall": "Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.", "address_2": "", "product_quantity": "unknown", "code_info": "All Lots", "center_classification_date": "20180228", "distribution_pattern": "NY and NJ through six retail stores named \"Asian Food Markets\"", "state": "NY", "product_description": "MACA gold tablets,  6800 mg, 10-count bottle, labeling is in foreign language", "report_date": "20180207", "classification": "Class I", "openfda": {}, "recalling_firm": "A&H Focal Inc.", "recall_number": "D-0571-2018", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "76644", "termination_date": "20190614", "more_code_info": "", "recall_initiation_date": "20170307", "postal_code": "10305-4445", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0313-2018", "product_description": "Professional Hospital Supply Suture Removal Kit, Sterile, Single Use Only. Packaged in Mexico for Professional Hospital Supply, Inc., 41980 Winchester Rd., Temecula, CA 92590", "product_quantity": "779 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: P888899; Lots 17RB8659; 17GB5162  Pack Number: P888899H; Lots 17RB8659", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81004", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-0086-2019", "product_description": "Cortaid 12-Hour Advanced Anti-itch Cream (1% hydrocortisone), NET WT 1.5 oz. (42 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875519155", "product_quantity": "5,016 tubes", "reason_for_recall": "CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.", "recall_initiation_date": "20180824", "center_classification_date": "20181022", "termination_date": "20200306", "report_date": "20181031", "code_info": "Lot #: 172185F, Exp 6/19"}, {"country": "United States", "city": "Princeton", "address_1": "107 College Rd E", "reason_for_recall": "Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.", "address_2": "", "product_quantity": "2280 bottles", "code_info": "T60045", "center_classification_date": "20180814", "distribution_pattern": "U.S.A. Nationwide", "state": "NJ", "product_description": "Atorvastatin Calcium tablets, 40 mg, 500-count bottle, Rx only, Mfd By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 India, NDC 55111-123-05", "report_date": "20180822", "classification": "Class III", "openfda": {"application_number": ["ANDA091650"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-121", "55111-122", "55111-123"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617310", "617311", "617312"], "spl_id": ["36e09eff-3948-2638-b633-d5ec2bc03d2a"], "spl_set_id": ["901550e6-22be-68c9-eb86-f85a9c9dd998"], "package_ndc": ["55111-121-30", "55111-121-60", "55111-121-90", "55111-121-05", "55111-121-10", "55111-122-30", "55111-122-60", "55111-122-90", "55111-122-05", "55111-122-10", "55111-123-30", "55111-123-60", "55111-123-90", "55111-123-05", "55111-123-10"], "is_original_packager": [true], "upc": ["0355111123903"], "unii": ["48A5M73Z4Q"]}, "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "recall_number": "D-1079-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80675", "termination_date": "20200415", "more_code_info": "", "recall_initiation_date": "20180802", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]